handl Group has signed an exclusive deal to provide mental healthcare company Limbic’s service as a bespoke offering for the B2B market.
The partnership means that Limbic – a provider of AI-based mental healthcare services – will be available outside the NHS for the first time. The platform is currently available in five NHS Improving Access to Psychological Therapies (IAPT) services in the UK, where it serves thousands of patients. It is the latest step in the drive by handl – a portfolio group of companies serving the legal, insurance and healthcare sectors – to build its ‘people plus tech’ propositions.
The web-based Limbic service brings a raft of benefits for everyone involved, from speedier treatment and improved outcomes to reduced costs for insurers. handl Group’s Chief Commercial Officer Chris Chatterton, said:
“We continue to scour the market for the best cutting edge technology available, and Limbic is the tool we’ve selected to enhance our psychological networks. This is far from a mindfulness app; it is an AI therapy assistant that amplifies the power of clinicians through data, rather than seeking to replace them. Limbic has already been successful in the NHS, and the platform’s ability to reduce patient wait times and barriers to service access are particularly welcome at the moment, as we see an increased demand for mental health support networks.”
Ross Harper, CEO and Co-founder of Limbic, commented:
“We are delighted to be teaming up with handl Group on this. It is a crucial time for mental healthcare, where digital solutions like ours need to bridge the gap between patient demand and clinical capacity. Our partnership with handl Group will enable us to take mental healthcare beyond the NHS and ensure we are able to provide speedier access to support for as many people as possible.”
Limbic’s platform uses conversational AI to deliver NICE [National Institute for Health Care Excellence] approved therapies to patients.
The platform can be used from when the patient first enters the waiting list through to post-recovery, and throughout the process uses data from clinicians and patients to personalise the product and facilitate remote monitoring.
As well as cutting the time between referral and treatment, Limbic’s benefits include:
· rapid information gathering to inform appropriate treatment programmes
· diversion of clinical resources to support those who require human intervention only
· clear indication of type, duration and therefore cost of treatment at the outset
· reduced referral and treatment costs – the NHS has achieved significant savings via major reductions in waiting times and admin costs
· relieves pressure on clinicians: there are an estimated 1.1million people using the whole range of psychotherapy services, but only 31,000 psychologists – the Royal College of Psychiatrists is predicting a post-Covid “tsunami” of mental illness